Abbott says it could take months to meet demand for baby formula

Abbott says it could take months to meet demand for baby formula

  • Abbott says it could reopen its Michigan plant in two weeks if the FDA approves it.
  • But even then, they say it will take 6-8 weeks to get formulas on the shelves.
  • In the meantime, the FDA is working to address a nationwide shortage of infant formula.

Abbott, the company that produces formula, said if the FDA approves the reopening of its Michigan plant, it could do so in two weeks – but it would still take months to see formula on the shelves.

The company recalled several batches of formula brands Similac, Alimentum and EleCare in February following complaints that infants contracted cronobacter sakazakii, an environmental bacteria. All four babies used formula produced at the company’s facilities in Sturgis, Michigan.

The recall has exacerbated a nationwide shortage of infant formula.

Despite Abbott’s timeline, The Washington Post reported that the FDA was still not done investigating the facility.

The FDA report says cronobacter sakazakii bacteria were found in a number of areas of the facility and other safety protocols, such as the wearing of gloves by employees, were not followed.

“The plant remains closed as the company works to correct findings related to processes, procedures and conditions that the FDA observed during its inspection of the facility, which raised concerns that the Powdered infant formula produced at this facility prior to FDA inspection carries a risk of contamination,” an FDA spokeswoman told the Post.

In the meantime, with more than 40% of major infant formulas out of stock, the FDA mentioned all US-based formula makers have ramped up production in recent weeks, and more products should hit shelves soon.

Abbott also said it was shipping products made at its factory in Cootehill, Ireland, “to serve the special supplementary nutrition program for women, infants and children (WIC) consumers.”

Additionally, to ease the burden on parents, the Post reported that Califf said the FDA plans to let foreign manufacturers and suppliers ship products to the United States.

“The FDA is working closely with our federal government partners to safely bring as many infant formulas to U.S. shelves as quickly as possible. This is a top priority for the FDA. Our team will continue to work around the clock to resolve current supply issues as quickly as possible,” FDA Commissioner Robert Califf said in a statement. Tweeter.

Leave a Reply

Your email address will not be published.